Meric-Bernstam F - Search Results

1

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency.

Sun C, Yin J, Fang Y, Chen J, Jeong KJ, Chen X, Vellano CP, Ju Z, Zhao W, Zhang D, Lu Y, Meric-Bernstam F, Yap TA, Hattersley M, O'Connor MJ, Chen H, Fawell S, Lin SY, Peng G, Mills GB. Sun C, et al. Cancer Cell. 2018 Mar 12;33(3):401-416.e8. doi: 10.1016/j.ccell.2018.01.019. Cancer Cell. 2018. PMID: 29533782 Free PMC article.

2

Molecular therapeutics: promise and challenges.

Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB. Kohn EC, et al. Semin Oncol. 2004 Feb;31(1 Suppl 3):39-53. doi: 10.1053/j.seminoncol.2004.01.009. Semin Oncol. 2004. PMID: 15052542 Review.

3

Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.

Mondesire WH, Jian W, Zhang H, Ensor J, Hung MC, Mills GB, Meric-Bernstam F. Mondesire WH, et al. Clin Cancer Res. 2004 Oct 15;10(20):7031-42. doi: 10.1158/1078-0432.CCR-04-0361. Clin Cancer Res. 2004. PMID: 15501983

4

Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.

Dong J, Peng J, Zhang H, Mondesire WH, Jian W, Mills GB, Hung MC, Meric-Bernstam F. Dong J, et al. Cancer Res. 2005 Mar 1;65(5):1961-72. doi: 10.1158/0008-5472.CAN-04-2501. Cancer Res. 2005. PMID: 15753396

5

Mammalian target of rapamycin.

Meric-Bernstam F, Mills GB. Meric-Bernstam F, et al. Semin Oncol. 2004 Dec;31(6 Suppl 16):10-7; discussion 33. doi: 10.1053/j.seminoncol.2004.10.013. Semin Oncol. 2004. PMID: 15799239 Review.

6

BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.

Rai R, Dai H, Multani AS, Li K, Chin K, Gray J, Lahad JP, Liang J, Mills GB, Meric-Bernstam F, Lin SY. Rai R, et al. Cancer Cell. 2006 Aug;10(2):145-57. doi: 10.1016/j.ccr.2006.07.002. Epub 2006 Jul 27. Cancer Cell. 2006. PMID: 16872911 Free PMC article.

7

Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Yim EK, Peng G, Dai H, Hu R, Li K, Lu Y, Mills GB, Meric-Bernstam F, Hennessy BT, Craven RJ, Lin SY. Yim EK, et al. Cancer Cell. 2009 Apr 7;15(4):304-14. doi: 10.1016/j.ccr.2009.02.012. Cancer Cell. 2009. PMID: 19345329 Free PMC article.

8

Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.

Zou CY, Smith KD, Zhu QS, Liu J, McCutcheon IE, Slopis JM, Meric-Bernstam F, Peng Z, Bornmann WG, Mills GB, Lazar AJ, Pollock RE, Lev D. Zou CY, et al. Mol Cancer Ther. 2009 May;8(5):1157-68. doi: 10.1158/1535-7163.MCT-08-1008. Epub 2009 May 5. Mol Cancer Ther. 2009. PMID: 19417153

9

Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.

Luyimbazi D, Akcakanat A, McAuliffe PF, Zhang L, Singh G, Gonzalez-Angulo AM, Chen H, Do KA, Zheng Y, Hung MC, Mills GB, Meric-Bernstam F. Luyimbazi D, et al. Mol Cancer Ther. 2010 Oct;9(10):2770-84. doi: 10.1158/1535-7163.MCT-09-0980. Epub 2010 Sep 28. Mol Cancer Ther. 2010. PMID: 20876744 Free PMC article.

10

Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis.

McAuliffe PF, Meric-Bernstam F, Mills GB, Gonzalez-Angulo AM. McAuliffe PF, et al. Clin Breast Cancer. 2010 Nov;10 Suppl 3:S59-65. doi: 10.3816/CBC.2010.s.013. Clin Breast Cancer. 2010. PMID: 21115423 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

672 results

Search Page